Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |